0001193125-12-003682.txt : 20120106 0001193125-12-003682.hdr.sgml : 20120106 20120106095256 ACCESSION NUMBER: 0001193125-12-003682 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20120105 DATE AS OF CHANGE: 20120106 EFFECTIVENESS DATE: 20120105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harbor BioSciences, Inc. CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-101219 FILM NUMBER: 12513288 BUSINESS ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE STREET 2: SUITE 180 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-587-9333 MAIL ADDRESS: STREET 1: 9171 TOWNE CENTRE DRIVE STREET 2: SUITE 180 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19970410 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 S-8 POS 1 d277500ds8pos.htm POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8

As filed with the Securities and Exchange Commission on January 5, 2012

Registration No. 333-92185

Registration No. 333-51286

Registration No. 333-65712

Registration No. 333-101219

Registration No. 333-106860

Registration No. 333-121216

Registration No. 333-130670

Registration No. 333-136555

Registration No. 333-148088

Registration No. 333-156111

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-92185

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-51286

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-65712

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-101219

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-106860

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-121216

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-130670

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-136555

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-148088

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM S-8

REGISTRATION STATEMENT NO. 333-156111

UNDER

THE SECURITIES ACT OF 1933

 

 

HARBOR BIOSCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   13-3697002

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

 

9191 Towne Centre Drive, Suite 409

San Diego, California 92122

(Address of Principal Executive Offices and Zip Code)

 

 

1997 Incentive Stock Option Plan

Hollis-Eden Pharmaceuticals, Inc. Discretionary Contribution Plan

2005 Equity Incentive Plan

2005 Non-Employee Directors’ Equity Incentive Plan

Amended 401(k) Plan

(Full titles of the plans)

 

 

Robert W. Weber

Chief Financial Officer and Secretary

Harbor BioSciences, Inc.

9191 Towne Centre Drive, Suite 409

San Diego, California 92122

(Name and address of agent for service)

(858) 587-9333

(Telephone number, including area code, of agent for service)

 

 

Copies to:

Michael J. Brown, Esq.

Ryan C. Wilkins, Esq.

Stradling Yocca Carlson & Rauth

4365 Executive Drive, Suite 1500

San Diego, California 92121

(858) 926-3000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨    Smaller reporting company   x

 

 

 


TERMINATION OF REGISTRATION

These post-effective amendments (the “Post-Effective Amendments”) relate to the following Registration Statements on Forms S-8 (collectively, the “Registration Statements”) filed by Harbor BioSciences, Inc. (the “Registrant”) with the Securities and Exchange Commission (the “Commission”):

 

 

Registration No. 333-92185 filed on Form S-8 on December 6, 1999, registering (i) 2,199,834 shares of the Registrant’s Common Stock, par value $0.01 per share (“Common Stock”) under the 1997 Incentive Stock Option Plan, (ii) 50,000 of the Registrant’s Common Stock under the Hollis-Eden Pharmaceuticals, Inc. Discretionary Contribution Plan and (iii) 300,000 shares of the Registrant’s Common Stock underlying options granted outside the 1997 Incentive Stock Option Plan;

 

 

Registration No. 333-51286 filed on Form S-8 on December 5, 2000, registering 500,000 shares of the Registrant’s Common Stock under the 1997 Incentive Stock Option Plan;

 

 

Registration No. 333-65712 filed on Form S-8 on July 24, 2001, registering (i) 500,000 shares of the Registrant’s Common Stock under the 1997 Incentive Stock Option Plan and (ii) 100,000 shares of the Registrant’s Common Stock under the Hollis-Eden Pharmaceuticals, Inc. Discretionary Contribution Plan;

 

 

Registration No. 333-101219 filed on Form S-8 on November 15, 2002, registering 500,000 shares of the Registrant’s Common Stock under the 1997 Incentive Stock Option Plan;

 

 

Registration No. 333-106860 filed on Form S-8 on July 7, 2003, registering 650,000 shares of the Registrant’s Common Stock under the 1997 Incentive Stock Option Plan;

 

 

Registration No. 333-121216 filed on Form S-8 on December 13, 2004, registering 750,000 shares of the Registrant’s Common Stock under the 1997 Incentive Stock Option Plan;

 

 

Registration No. 333-130670 filed on Form S-8 on December 23, 2005, registering (i) 450,000 shares of the Registrant’s Common Stock under the 2005 Equity Incentive Plan, (ii) 150,000 shares of the Registrant’s Common Stock under the 2005 Non-Employee Directors’ Equity Incentive Plan, (iii) 100,000 shares of the Registrant’s Common Stock under the Amended 401(k) Plan and (iv) 197,500 shares of the Registrant’s Common Stock underlying options granted outside of the 1997 Incentive Stock Option Plan and the 2005 Equity Incentive Plan;

 

 

Registration No. 333-136555 filed on Form S-8 on August 11, 2006, registering (i) 500,000 shares of the Registrant’s Common Stock under the 2005 Equity Incentive Plan and (ii) 150,000 shares of the Registrant’s Common Stock under the 2005 Non-Employee Directors’ Equity Incentive Plan;

 

 

Registration No. 333-148088 filed on Form S-8 on December 14, 2007, registering (i) 1,500,000 shares of Common Stock under the 2005 Equity Incentive Plan and (ii) 150,000 shares of the Registrant’s Common Stock under the 2005 Non-Employee Directors’ Equity Incentive Plan; and

 

 

Registration No. 333-156111 filed on Form S-8 on December 12, 2008, registering (i) 800,000 shares of Common Stock under the 2005 Equity Incentive Plan and (ii) 150,000 shares of the Registrant’s Common Stock under the 2005 Non-Employee Directors’ Equity Incentive Plan.

The Registrant deregistered its Common Stock under Section 12(g) of the Securities Exchange Act of 1934, as amended, through the filing of a Form 15 with the Commission on August 15, 2011. In connection with the Form 15 filing and in accordance with an undertaking made by the Registrant in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities that had been registered for issuance that remain unsold at the termination of the offering, the Registrant is hereby deregistering the remaining securities registered but unsold under the Registration Statements as of the date of these Post-Effective Amendments.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on January 5, 2012.

 

  HARBOR BIOSCIENCES, INC.
By:  

/s/ Robert W. Weber

  Robert W. Weber
  Chief Financial Officer and Secretary

Pursuant to the requirements of the Securities Act of 1933, these Post-Effective Amendments to the Registration Statements have been signed by the following persons in the capacities and on the date indicated.

 

Signature

  

Title

 

Date

/s/ James M. Frincke

James M. Frincke

  

President, Chief Executive Officer and Director

(Principal Executive Officer)

  January 5, 2012

/s/ Robert W. Weber

Robert W. Weber

  

Chief Financial Officer and Secretary

(Principal Financial Officer and Principal Accounting Officer)

  January 5, 2012

*

Salvatore J. Zizza

   Chairman of the Board   January 5, 2012

*

Richard A. Bartlett

   Director   January 5, 2012

*

Jerome M. Hauer

   Director   January 5, 2012

*

Marc R. Sarni

   Director   January 5, 2012

*

Jerry M. Seslowe

   Director   January 5, 2012

*

John C. Shaw

   Director   January 5, 2012

*     By:

 

/s/ Robert W. Weber

     January 5, 2012
 

Robert W. Weber

Attorney-in-Fact

(Pursuant to a Power of Attorney)

    


EXHIBIT INDEX

 

Exhibit
Number

  

Exhibit

24.1    Power of Attorney.
EX-24.1 2 d277500dex241.htm POWER OF ATTORNEY Power of Attorney

Exhibit 24.1

POWER OF ATTORNEY

Each of the undersigned hereby constitutes and appoints Robert W. Weber as the undersigned’s true and lawful attorney-in-fact to:

(1) execute for and on behalf of each of the undersigned any and all of the following amendments to registration statements and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission (the “SEC”):

 

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-56155;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-56157;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-69725;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-69727;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-72853;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-92179;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-96181;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-34180;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-51284;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-75860;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-83372;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-101221;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-103831

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-103851;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-105378;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-106835;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-113644;

   

Post-Effective Amendment No. 2 to Form S-3 Registration Statement No. 333-126458;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-135095;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-136554;

   

Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-163936;

   

Post-Effective Amendment No. 3 to Form S-4 Registration Statement No. 333-18725;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-92185;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-51286;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-65712;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-101219;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-106860;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-121216;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-130670;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-136555;

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-148088; and

   

Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-156111;


(2) do and perform any and all acts for and on behalf of each of the undersigned which may be necessary or desirable to enable Harbor BioSciences, Inc. to comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the SEC in connection with any such documentation; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, each of the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of each of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

Each of the undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as each of the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.

This Power of Attorney shall remain in full force and effect until the attorney-in-fact is no longer required to execute any such documentation and do and perform any such acts related thereto, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, each of the undersigned has caused this Power of Attorney to be executed as of this 23rd day of November, 2011.

 

/s/    Salvatore J. Zizza     /s/    Richard A. Bartlett
Salvatore J. Zizza     Richard A. Bartlett
/s/    Jerome M. Hauer     /s/    Marc R. Sarni
Jerome M. Hauer     Marc R. Sarni
/s/    Jerry M. Seslowe     /s/    John C. Shaw
Jerry M. Seslowe     John C. Shaw